We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Par Wins Reprieve From Appeals Court in Patent Fight to Protect AIDS Drug
Par Wins Reprieve From Appeals Court in Patent Fight to Protect AIDS Drug
TWi Pharmaceuticals’ bid to market a generic version of Par Pharmaceutical’s AIDS drug Megace ES was dealt a major blow last month after a federal appeals court overturned a lower court’s ruling that had cleared the way for the product.